Antimicrobial-eluting cement orbital implant: a case report of staged enucleation for infectious panophthalmitis with extraocular extension

Orbit. 2023 Apr;42(2):201-205. doi: 10.1080/01676830.2021.1980893. Epub 2021 Sep 27.

Abstract

There are various orbital implant options following enucleation. In cases of severe infection, such as panophthalmitis with extraocular extension, it is reasonable to consider a two-staged approach to decrease the risk of infectious complications. One option, illustrated by this case, is enucleation with insertion of an antimicrobial-eluting cement implant, followed by a secondary procedure to exchange the cement with a permanent orbital implant. We report on a patient with clinical, ultrasound, and radiographical findings consistent with infectious panophthalmitis with extra-scleral extension. Intolerable pain and progressive orbital involvement in a blind eye were the indications for enucleation. To reduce the risk of persistent infection, a gentamycin-eluting cement implant (Palacos® R + G as an intraorbital implant) was utilized in the initial procedure. Two months later, the cement implant was removed, and a scleral-wrapped porous implant was placed into a quiet socket without signs of inflammation or infection. In the setting of severe infection, a two-staged procedure utilizing an antimicrobial-eluting implant can be considered.

Keywords: Antimicrobial-eluting implant; cement implant; drug-eluting implant; enucleation; implant; orbit; panophthalmitis.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents*
  • Eye Enucleation
  • Humans
  • Orbit / surgery
  • Orbital Implants*
  • Panophthalmitis* / surgery
  • Postoperative Complications
  • Prosthesis Implantation / methods
  • Retrospective Studies

Substances

  • Anti-Infective Agents